Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes
Open Access
- 12 October 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 31 (1) , 50-58
- https://doi.org/10.1093/eurheartj/ehp401
Abstract
AimsIn patients with acute coronary syndromes (ACS), the negative impact of baseline haemoglobin levels on ischaemic events, particularly death, is well established, but the association with bleeding risk is less well studied. The aim of this study was to assess the impact of baseline haemoglobin levels on major bleeding complications.Methods and resultsPooled analysis of OASIS 5 and 6 data involving 32 170 patients with ACS with and without ST-segment elevation was performed. The association between baseline haemoglobin and major bleeding or ischaemic events was examined using multiple regression model. Main outcome measures were 30-day rates of major bleeding, death, and death/myocardial infarction (MI) analysed according to baseline haemoglobin levels. Baseline haemoglobin level independently predicted the risk of overall, procedure-related, and non-procedure-related major bleedings at 30 days [odds ratio (OR) 0.94, 95% CI 0.90–0.98; OR 0.94, 95% CI 0.90–0.99; and OR 0.89, 95% CI 0.83–0.95, respectively, per 1 g/dL haemoglobin increment above 10 g/dL]. In addition, a curvilinear relationship between baseline haemoglobin levels and death at 30 days was observed with a 6% decrease in the risk for every 1 g/dL haemoglobin increment above 10 g/dL up to 15.9 g/dL (OR 0.94, 95% CI 0.90–0.98) and a 19% increase above this value (OR 1.19, 95% CI, 0.98–1.43). A similar relationship for the composite outcome of death/MI was observed.ConclusionA low baseline haemoglobin level is an independent predictor of the risk of major bleeding in ACS as well as of the risk of death and death and MI. Among other predictors of bleeding risk, baseline haemoglobin should be taken into account in patients presenting with ACS.Clinical trial registration: ClinicalTrials.gov number, NCT00139815.http://clinicaltrials.gov/ct2/show/NCT00139815?term=NCT00139815&rank=1.Keywords
This publication has 38 references indexed in Scilit:
- Impact of Preoperative Anemia on Outcome in Patients Undergoing Coronary Artery Bypass Graft SurgeryCirculation, 2007
- Hematocrit, Independent of Chronic Kidney Disease, Predicts Adverse Cardiovascular Outcomes in Chinese Patients With Type 2 DiabetesDiabetes Care, 2006
- Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologistsInternational Urology and Nephrology, 2006
- Anemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetesCardiovascular Diabetology, 2006
- Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and AnemiaAmerican Journal of Kidney Diseases, 2005
- Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary SyndromesCirculation, 2005
- Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the controlled abciximab and device investigation to lower late angioplasty complications (cadillac) trialPublished by Elsevier ,2004
- Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary InterventionCirculation, 2004
- Effect of anemia on 1-year mortality in patients with acute myocardial infarctionAmerican Heart Journal, 2002
- Effect of anaemia and cardiovascular disease on surgical mortality and morbidityThe Lancet, 1996